Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies

The number of adults with SMA is expected to continue to grow, and thus, a greater need exists for healthcare professionals to improve their provision of age-appropriate care and ensure adults benefit from therapeutic advances. This program will provide targeted, clear, and concise information to help neurologists provide optimal, individualized care to their adult patients with SMA.

Share

Program Content

Activities

Disease modifying therapies for SMA
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Video
Congratulations: You achieved a completion on 04/09/2022

Released: March 13, 2024

Expires: March 12, 2025

Faculty

cover img faculity

Perry Shieh, MD, PhD

Professor (Health Sciences)
Departments of Neurology and Pediatrics
David Geffen School of Medicine at UCLA
University of California, Los Angeles
Los Angeles, California

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC, in partnership with Cure SMA.

Supporters

Supported by educational grants from Biogen and Genentech, a member of the Roche Group.

Biogen

Genentech, a member of the Roche Group

Partners

Cure SMA

ProCE Banner